ESH Congress was held from June 21-24th, 2019 in Milan, Italy. The ESH is a stable and organised European platform for scientific exchange in hypertension. Carbon Brand Solutions was indeed fortunate to attend and cover the exciting live sessions and interview some of the KOL’s who threw significant light on the different aspects of hypertension.
ESC Congress 2019 was held from 31 August 2019 to 04 September 2019 in Paris. The ESC is the world’s biggest social event of healthcare experts committed to battling heart diseases. Carbon Brand Solutions was blessed to cover a wide range of sessions and discussions on Global Cardiovascular Health. This exceptional, global social event furnishes healthcare experts with the most recent cardiovascular science so they can all the more likely care for their patients.
Serum uric acid levels are known to be highly associated with stroke, coronary artery disease as well as hypertension and metabolic syndrome.
With over 10,000 prescription drugs on the market and about one-third of all American adults receiving more than five medications daily, there is an excess of room for potential adverse drug events.
>90% of children born with CHD are expected to survive to adulthood because of enhancements in care for patients with congenital heart disease (CHD).
Heart failure (HF) endures a major public health complication despite significant advances in the prevention and treatment of cardiovascular disorder.
Ischemic heart disease (IHD) is influencing many parts of the world and becoming a major health issue.
Researchers have demonstrated that nearly one-third of all FDA-approved emerging therapeutics require new boxed warnings after hitting the market.
Nearly 50% of older adults take five or more medications, and at least one in five of these prescriptions is potentially inadequate.
Arrhythmias are a leading cause of hospitalization in adults with congenital heart disease (ACHD) and increase the risk of thromboembolic events and the risk of death by 50%.